Advanced Biomed Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-05-01. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Xiaomin Chen, Chief Executive Officer, effective 2026-04-28
Upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.
Departing: Fang Cheng, Chief Technology Officer, effective 2026-03-25
On March 25, 2026, Steven I-Fang Cheng notified Advanced Biomed Inc. (the "Company") of his resignation as a member of the Board of Directors and as Chief Technology Officer of the Company, effective as of March 25, 2026.
Appointed: Mingze Yin, Director, effective 2026-03-25
On March 25, 2026, upon the recommendation of the Nominating Committee, the Board of Directors appointed Mingze Yin, the Chief Financial Officer of the Company, as a director of the Company, effective as of March 25, 2026.
Find people with the same kind of experience as the Chief Executive Officer at Advanced Biomed Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Advanced Biomed Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Advanced Biomed Inc. is in the news or changes leadership.
Get an alert when Advanced Biomed Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Advanced Biomed Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.